|
Hippomane
|
B01.650.940.800.575.912.250.859.797.438.461 |
|
|
Adventitia
|
A07.015.057 |
|
|
Amino Acid Sequence
|
G02.111.570.060 |
|
|
Ear Protective Devices
|
J01.637.215.600.199 |
|
|
Mental Retardation, X-Linked
|
C10.597.606.360.455 |
|
|
Anthralin
|
D04.615.117.050 |
|
|
Cross-Cultural Comparison
|
I01.880.853.100.257 |
|
|
Fluorescent Antibody Technique, Indirect
|
E01.370.225.750.551.512.240.310 |
|
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
|
D03.383.725.547.900 |
|
|
National Longitudinal Study of Adolescent Health
|
E05.318.372.500.750.500.500 |
|
|
Longitudinal Studies
|
E05.318.372.500.750.500 |
|
|
Distal Myopathies
|
C16.320.577.074 |
|
|
ADAM12 Protein
|
D08.811.277.656.675.374.102.125 |
|
|
Fuel Oils
|
D20.345.630.500 |
|
|
Petroleum
|
D20.345.630 |
|
|
Cyclin D3
|
D12.644.360.262.150.300 |
|
|
Lingual Goiter
|
C16.131.894.500.500 |
|
|
Lingual Thyroid
|
C16.131.894.500 |
|
|
Consensus Development Conferences, NIH as Topic
|
N03.540.199.205.500 |
|
|
Consensus Development Conferences as Topic
|
N03.540.199.205 |
|
